Aadi Bioscience, Inc.AADINASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 50% recommend buying.

Consensus Rating
Buy
6 analysts·Limited coverage
50%
Rating Distribution
Strong Buy
00%
Buy
350%
Hold
350%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 20% above analyst consensus — significant downside expected.

Bear Case
$1.50
-27%
Consensus
$1.63
-20%
Bull Case
$1.75
+-15%
Price Range6 analysts
Low
Consensus
High
$1.50
$1.75
Current Target
Current Price
$2.05
Above Target
$0.42

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Aug 27, 2024Piper Sandler
Aadi Bioscience downgraded to Neutral from Overweight at Piper Sandler
Target:$1.75
+0.0%from $1.75
Aug 21, 2024Jefferies
Aadi Bioscience downgraded to Hold from Buy at Jefferies
Target:$1.50
-3.2%from $1.55